Chronic & Non Communicable Diseases
Prevention & Personalised Health
Cancer
Immune System
Genetics & Omics
Biomarkers
Ph.D
France
2011.09.30
Boosting the anti-tumoral properties of T lymphocytes via the CD28 costimulatory molecules
Our immune system defends us against external threats (bacteria and viruses) and internal threats (tumors). The immune response involves the action of several cells which communicate with each other to ensure our protection. Among these natural body guards are the T cells, which specifically fight against internal threats. Using innovative proteomics and genetic approaches, Margot Cucchetti is studying the complex series of molecular reactions that are involved in T-cell activation. She aims to understand how these pathways are closely regulated.
The results of her research will be an important step for developing strategies to target and enhance T-cell responses to tumors, thus helping our bodies to defend themselves against cancer. These studies will be of particular importance for developing vaccines for the aging population.
Your body can defend itself against cancer. It just needs a little help!
To add or modify information on this page, please contact us at the following address: community.research@axa.com
Margot
CUCCHETTI
Institution
Institut National de la Santé et de la Recherche Médicale
IH&P Institute
Country
France
Nationality
French
Related articles
Chronic & Non Communicable Diseases
Medical Treatment & Drug Development
Chronic Pain & Musculoskeletal Disorders
Drug Delivery
Biotech- and Nanotechnology
AXA Project
France
Pain Pediatric & Elderly AXA Research Lab (PEARL)
Chronic pain is recognized as a major public health problem affecting patients in their daily activity, physical and mental health,... Read more
Celine
GRECO